ACET
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
50.2M
32 days until earnings call
FLGC
Price
$0.60
Change
+$0.01 (+1.69%)
Updated
Jul 3 closing price
Capitalization
18.55M
Interact to see
Advertisement

ACET vs FLGC

Header iconACET vs FLGC Comparison
Open Charts ACET vs FLGCBanner chart's image
Adicet Bio
Price$0.61
Change-$0.00 (-0.00%)
Volume$545.98K
Capitalization50.2M
Flora Growth
Price$0.60
Change+$0.01 (+1.69%)
Volume$71.17K
Capitalization18.55M
ACET vs FLGC Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. FLGC commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and FLGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ACET: $0.61 vs. FLGC: $0.60)
Brand notoriety: ACET and FLGC are both not notable
ACET represents the Biotechnology, while FLGC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 99% vs. FLGC: 39%
Market capitalization -- ACET: $50.2M vs. FLGC: $18.55M
ACET [@Biotechnology] is valued at $50.2M. FLGC’s [@Pharmaceuticals: Other] market capitalization is $18.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileFLGC’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • FLGC’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than FLGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while FLGC’s TA Score has 2 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • FLGC’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ACET is a better buy in the short-term than FLGC.

Price Growth

ACET (@Biotechnology) experienced а -9.48% price change this week, while FLGC (@Pharmaceuticals: Other) price change was -5.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

FLGC is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACET($50.2M) has a higher market cap than FLGC($18.6M). ACET YTD gains are higher at: -36.902 vs. FLGC (-42.223). FLGC has higher annual earnings (EBITDA): -47.48M vs. ACET (-110.82M). ACET has more cash in the bank: 150M vs. FLGC (4.76M). FLGC has less debt than ACET: FLGC (3.12M) vs ACET (16.2M). FLGC has higher revenues than ACET: FLGC (72.4M) vs ACET (0).
ACETFLGCACET / FLGC
Capitalization50.2M18.6M270%
EBITDA-110.82M-47.48M233%
Gain YTD-36.902-42.22387%
P/E RatioN/AN/A-
Revenue072.4M-
Total Cash150M4.76M3,149%
Total Debt16.2M3.12M520%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETFLGC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RANI0.54N/A
+0.68%
Rani Therapeutics Holdings
EVH11.790.06
+0.51%
Evolent Health
AVO12.080.06
+0.50%
Mission Produce
TUSK2.800.01
+0.36%
Mammoth Energy Services
XYL131.71N/A
N/A
Xylem

FLGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLGC has been loosely correlated with SNDL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLGC
1D Price
Change %
FLGC100%
+0.08%
SNDL - FLGC
37%
Loosely correlated
+1.60%
ACET - FLGC
34%
Loosely correlated
-1.14%
CGC - FLGC
28%
Poorly correlated
+7.56%
SXTC - FLGC
26%
Poorly correlated
+5.62%
IMCC - FLGC
26%
Poorly correlated
+12.12%
More